Invest Like the Best with Patrick O'Shaughnessy - Josh Wolfe - This is Who You Are Up Against - [Invest Like the Best, EP.76]
Episode Date: February 13, 2018Long-time listeners will have heard me joke before that this podcast should really be called “this is who are you up against.” I’ve been waiting for the right episode to deploy the joke as a tit...le, and this week we have it. The joke is meant to convey how incredibly impressive these people are who we get to hear from every week. My guest this week is Josh Wolfe, a founding and managing partner at Lux Capital in New York City. Lux is a venture capital firm, but a highly unique one. They’ve spent more time in hard sciences and interesting nooks and crannies of the market than the typical VC firm. Some of investing is zero sum: my outperformance is someone else’s underperformance. Sometimes, though, investing is positive sum. The combination of capital, ideas, people, drive, and raw energy leads to amazing new things. I think the best investing and best investors of the future will be more collaborative than competitive. After finishing with Josh, I couldn’t stop thinking “god, do I want to be involved with whatever he’s doing, if only just to learn.” This conversation made me rethink my joke “this is who are you up against.” Now I won’t think of it as a zero-sum joke, but instead as a reminder: this is the kind of person who is out there. You better find your niche, and still be the absolute best you can within that niche. Please enjoy this killer conversation with Josh Wolfe. We cover just about everything. For more episodes go to InvestorFieldGuide.com/podcast. Sign up for the book club, where you’ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub. Follow Patrick on Twitter at @patrick_oshag Links Referenced Investing in Biofuels or Biofools? Ali Hamed podcast Alex Moazed podcast Andy Rachleff podcast Popplet @wolfejosh Books Referenced Modern Monopolies: What It Takes to Dominate the 21st Century Economy World After Capital Show Notes 2:35 – (First Question) – Lux Capital and the kind of investments they have made over the years 5:42 – The formation of the investment philosophy for Lux 9:52 – Investment philosophy 100-0-100 (ambition, arrogance, intellectual humility) 10:40 – How Josh manages his time and attention 12:53 – Investing in Biofuels or Biofools? 13:29 – Obsession with nuclear 18:28 – Focus on autonomous vehicles 21:02 – How all of these gambles are viewed by Josh’s investors 22:56 – Tattoo technology 24:20 – Ali Hamed podcast 24:36 – How Josh evaluates people when considering early stage investments 24:45 – Alex Moazed podcast 24:49 – Modern Monopolies: What It Takes to Dominate the 21st Century Economy 29:50 – Memorable experience investing in a founder 30:44 – The idea of thesis driven approach to private investment 30:56 – Andy Rachleff podcast 32:38 – Crazy thesis – understanding the emotional needs of our pets 38:03 – Josh’s learning process through these theses 38:34 – Popplet 45:49 – Investors that Josh has learned the most from 47:37 – Josh’s comfort investing outside of his usual asset class 49:03 – @wolfejosh 50:56 – What is the thinking with the short strategy at Lux 52:31 – SpaceX vs Tesla, good business vs bad business 53:42 – How Josh approaches the quality of a business 54:15 – World After Capital 55:16 – How does Josh evaluate competitive advantage 56:45 – Where are we in the venture capital landscape 1:01:42 – How does his outlook on venture capital affect the way Lux is run 1:02:48 – Thoughts on cryptocurrency 1:07:22 – What is the most memorable conversation Josh has ever had 1:09:34 – What is Josh’s objective function in life 1:12:43 – Are there people that Josh disagrees with but deeply respects 1:13:32 – Kindest thing anyone has ever done for Josh Learn More For more episodes go to InvestorFieldGuide.com/podcast. Sign up for the book club, where you’ll get a full investor curriculum and then 3-4 suggestions every month at InvestorFieldGuide.com/bookclub Follow Patrick on twitter at @patrick_oshag
Transcript
Discussion (0)
This podcast is sponsored by CFA Institute, the Global Association of Investment Professionals
whose mission is to lead the investment profession by promoting the highest standards of
ethics, education, and professional excellence for the ultimate benefit of society.
CFA Institute serves a global community of investment professionals working to build an
investment industry where investors' interests come first, financial markets function at their
best, and economies grow.
The chartered financial analyst credential is the most respected and recognized investment
management designation in the world.
The views expressed in this podcast do not necessarily represent the views of CFA Institute.
Hello and welcome, everyone.
I'm Patrick O'Shaughnessy and this is Invest Like the Best.
This show is an open-ended exploration of markets, ideas, methods, stories, and of strategies
that will help you better invest both your time and your money.
You can learn more and stay up to date at investorfieldguide.com.
Patrick O'Shaughnessy is the CEO of O'Shaunicee Asset Management.
All opinions expressed by Patrick and podcast guests are solely their own opinions and do not reflect the opinion of O'Shaun's the asset management.
This podcast is for informational purposes only and should not be relied upon as a basis for investment decisions.
Clients of O'Shaughnessy asset management may maintain positions and the securities discussed in this podcast.
Longtime listeners will have heard me joke before that this podcast should really be called This Is Who You Are Up Against.
I've been waiting for the right episode to deploy the joke as a title and this week we have it.
The joke's meant to convey how incredibly impressive these people are who we get to hear from every week.
My guest this week is Josh Wolfe, a founding and managing partner at Lux Capital in New York City.
Lux is a venture capital firm, but a highly unique one.
They've spent more time in the hard sciences and interesting nooks and crannies to the market than a typical VC firm.
Some of investing is zero sum.
My outperformance is someone else's underperformance.
Sometimes, though, investing is positive sum.
The combination of capital, ideas, people, drive, and raw energy leads to amazing.
new things. I think the best investing and the best investors of the future will be more
collaborative than competitive. After finishing with Josh, I couldn't stop thinking, God, do I want to
be involved in whatever he's doing, if only just to learn. This conversation made me rethink my joke.
Now I won't think of it as a zero-sum joke, but instead as a reminder, this is the kind of
person who is out there. You better find your niche and still be the absolute best you can within
that niche. Please enjoy this amazing conversation. Josh and I cover just about everything.
So Josh, we were talking before we hit record about the many things that Lux Capital does,
and that'll be a great place to start just to give people a frame of reference for the sorts of investments that you've made over the years.
And then we'll go very deep into a number of different disparate topics that I know we're both very interested in.
The firm is pretty rangy.
We're a billion and a half.
And most recent fund was 400 million.
We got a $300 million co-invest fund.
And we do everything from super early seed stage things where you've got an entrepreneur in a garage, although often they're in our office, to a large division of a
corporation that we're going to spin out and recapitalize. And generally, it's along three areas.
So we consider it energy materials is one bucket. And then healthcare is another bucket, which is
everything from healthcare IT, which is generally low barriers and capital efficient. I tend
not to love that stuff as much. And then I really love the things where it's like really hard
and typically really expensive. So robotic surgery and med devices and biotech. And then the final third
is core technology, which is more defined by what we don't do. So very little, if anything,
in internet, social media, mobile, ad tech, video games. Things that generally every other VC
is doing. And really it's for two reasons. One that's intellectually honest and germane to us,
and one about the field. So if you're an amazing internet entrepreneur, you should be going to
Sequoia or Axel or benchmark. And we've always wanted to sort of avoid the adverse selection.
But if you're intellectually honest about the space, the great virtue that everybody talks about
is it's really cheap and capital efficient to start these businesses, which is true. But the
corresponding vice is that you get 5,000 global competitors to companies like Groupon. And so as an
investor, then you either spray and prey, which is buy really cheap lottery tickets and hope for a
high-magnitude payoff that are improbable, or, and you've seen some very famous venture franchises
do this, they migrate into something that we call wait and pay, where you're basically waiting
until a winner emerges. You have a higher probability of being correct, but obviously the higher
the price you pay, the lower your expected return. So I like to find things where there's really
high scientific and technical complexity so people sort of don't understand something yet. And we
sort of pride ourselves. Like we're contrarian. We like to think differently. But the truth is, we want
people to agree with us just later. So really high scientific and technical complexity,
intellectual property that imposes a negative right on you.
Says you can't do what these guys do legally because of composition of matter or some end field of use.
And then behaviorally, which I know you follow a lot, this sort of triptake of scarcity.
So scarcity of attention.
The media is not hyped up on it yet.
People don't know about it.
Scarcity of people.
The number of entrepreneurs that actually run a business are a few and far between.
And then scarcity of capital because if investors aren't chasing something, then necessarily valuations will be low.
And if we're right, then return should be high.
And then on top of that, we do thesis-driven stuff, which is my favorite, read voraciously,
try to understand what the consensus is, find a variant perception, something that people aren't
thinking about and generally for the wrong reason. We've got some cool examples of that. And then other
partners here love doing people-driven stuff. So find an amazing entrepreneur or set of them and back
her or him time and time again, and you build a portfolio of people. And then the final are special
situations, which is can you invest in a late-stage business but at an early-stage price?
And what causes that? A capital market dislocation, a corporate divestiture, a spinoff,
but generally somebody else took time and money risk and didn't get paid for it.
And then technology risk is gone or science risk or market risk is gone. And we get to come in
at a very early stage price. And you sort of can get that same sort of 10x in five year profile,
but a later stage business. It's a lot going on there. And it would help to go back to the
earliest days of Lux and hear a bit about the formation or formative elements of the investment
philosophy. So it actually sounds very much like a lot of value type investor mindset stuff
applied to private early stage businesses, but not necessarily private equity businesses. So it's
really unique. So I'd be fascinated to hear how, how that kernel, what the kernel was that led to
that early investment philosophy. When we got started, we went out to raise friends and family money.
I always joke that we had a lot of friends and we had a lot of family, but none of them had any
money. I grew up in Coney Island, Brooklyn. Mom was a school teacher. My co-founder Peter Aber,
grew up in Stanford, Connecticut, and we met, I was investment banking at Sali. He was at Lehman
Brothers in Equity Research. And we had this idea at a time when everybody was chasing dot coms
and optical networking that we were going to focus on the hard sciences. So it started with this
sort of definitional focus on an area that we thought was totally neglected. And even the derivation,
the etymology of Lux, Latin for Light, was looking where other people weren't looking. And so we said,
let's go after the chemistry, physics, material science departments. And then we met a guy,
Bill Conway, who's one of the founders of Carlisle, which literally changed the trajectory of our
life. And Bill put us in business and asked us probably the two most important questions that anybody had.
Number one, why should you exist? Why does the world need an incremental venture fund? There's a thousand
them out there. And number two, if your hypothesis is right that these are the next waves,
what is going to stop Kleiner and Sequoian benchmark in Excel from blowing you out of the water
and turning their turts on you? And they agree with you. And so we spent the first few years
building this platform where we developed a bunch of sort of sub-divisions underneath the
management company where we had a media business with Forbes. We had some public policy efforts.
We created a research business called Lux Research. All of these things were intended in the
early days so that if you were an entrepreneur, every venture guy says the same two BS things.
We're value-ahead investors. And we've got proprietary.
very deal flow. And we wanted actually something that was real value because people didn't know
who Lux was. They didn't know who Joshua Peter were. And so we had to have something that was like
structural and real and tangible. And so now with these different entities, if you were an entrepreneur,
we could get you tens of millions of dollars of non-dilutive government money or foundation money.
We could get you partnerships with Intel and Kodak and HP and Saudi Aramco that were the clients of
our research business. And we can get you visibility in the media with full disclosure because
as Conway admonished to us early on, 10 years to build a rep, 10 seconds to lose it.
it. So just anytime you ever write about it, anybody just full disclosure. And that became this
platform. And then from there, we raised subsequently larger funds and had better deal flow and
better reputation. And I always say, I call this randomness and optionality, ex post facto. You can
explain everything as like this perfect linear chain of events. But a priori, if you're intellectually
honest, you have no idea. So, you know, you meet everybody and you talk to everybody and you
learn as much as you can. And then one piece falls into the other and you look back. You're like,
oh, okay, yeah, it all made sense. That seems like a really interesting idea to pick a part a bit.
So randomness and optionality.
I'm a huge subscriber to those ideas, but I'd love to hear your formation of it and why that's important to you.
It was more of an observation that so many things in my life happened and not a religious person at all.
But I would look at these things and say, okay, well, how did that happen?
And then post facto, you can trace these things, sort of curiously like, how did I meet that person?
Okay, well, I was at this cocktail party and I met this person whose brother-in-law knew this woman.
And then this woman was like, oh, you should talk to it.
And it's just when you trace that, it's so nonlinear and random.
We were talking before about ants foraging in a forest.
And there's complete uncertainty, and they're moving all about.
But then something happens in that process where they're able to very efficiently find food sources.
And so after the fact you can figure out how it all worked, but a priori, you have no idea.
And so how do you cultivate those two things?
Once you've recognized this kind of randomness and optionality as a driver of a lot of what happens,
do you try to push harder on those things and set yourself up for more randomness and more
optionality?
I do, and I think it's a very personality-driven thing.
So there are people that are partners at the firm who are much more linear thinkers.
And they have a very specific goal.
They say, okay, I have point B to get to on that point A.
What's the shortest path to that?
And I'm more meet everybody, talk to everybody, go to random lunches, go to parties.
I have information anxiety.
I skip a page in the newspaper.
I'm like, oh, you know, I got to go back because maybe there's a tidbit there that's going to change my life.
And just so it's probably not the healthiest thing because I'm insatiably curious and I want to meet everybody and I want to know a little bit about everything.
But it's a humbling thing because you just never know.
I'm highly confident that you just never know where the next thing is going to come from.
We even have an investment philosophy that, again, in hindsight, I've called this now 100,
100.
And it's this mix of ambition and arrogance and intellectual humility.
Okay.
So the arrogant part is the 100.
I am 100% certain that Lux will be investing in the most cutting-edge crazy things that you can imagine in the next two years.
The zero part is the intellectual humility.
I have no idea what those things will be. None. The next hundred is the ambition and the confidence, which is I know with near 100% certainty where we will find those things. And it's at the edge of our already cutting edge companies. And so as long as I stay curious and paranoid and ambitious and we listen in the boardrooms about the hard problems that these companies might be solving, it's just that's where the next thing comes from. But it's all random until after the fact.
Curious how you think about your time, because I have this same problem of, you know, insatiable curiosity seems like a good thing.
I think it is a good thing on balance, but it's definitely a bit of a double-edged sword and that there's this kind of flavor of the month type mentality.
Sometimes it can be hard to really be consistent and execute the 1% inspiration, 99% perspiration that's always in my head.
I'm curious how you manage that balance and that idea and just generally then how you manage your attention.
Everybody always says, you know, focus, focus, focus. And I've structured the firm and my position and my role in a
way where I don't have to focus. I get to talk to everybody and do everything. And now I have to focus
when I'm on a certain company boards or I'm pursuing an investment. And there are times and there are
sort of punctuated periods where I become psychotically obsessed with a particular area. And I go
really deep. And I know that I become obsessed with it because my wife or my partners are generally
like, shut up already about that thing. Right. And so I know like it's the only thing I'm talking
about. I can give you some examples of that. But the time allocation is the one thing. Like we know we don't
worry about capital allocation because you know that you can always make more money, you can always
sort of reverse a mistake, you can be creative about that. Time, zero sum, like it's just always running
out. And so you only know in hindsight if you waste a time or not. So for example, we allocate a portfolio,
but sometimes we do these new codes. And so that means literally one of the partner makes an explicit
decision they're going to take a significant amount of their personal time and found a new company.
And we're going to license the intellectual property. We're going to find the entrepreneur. We're going to
hunt down the thesis. We're going to construct the narrative. We're going to recruit the first 20 people
and the board and come up with the syndicate. That's an enormous amount of time. And we know a
priority. It might be wasted time. But we also have this colloquialism and it's sort of a cliche,
but that passion is the best predictor of success. And if somebody is psychotically passionate about
something, then they've got the fuel and the energy to go do that. And so that would be a good
allocation of time. What was the last passion? Well, I'll give you, okay, so the last one that
we realized was a contrarian idea when everybody was chasing clean tech and green tech, if you
remember in the venture world. This was like, you know, the bubble extraordinary. It was like religious
thinking, which to me generally I started looking at and saying, okay, what's the sort of the antithetical
view to this? And everybody was talking. I mean, famous people, John Dewar, Vinod Kosla, the best VCs in the
world about solar and wind and biofuels and ethanol. I wrote the scathing piece in Forbes at some point,
calling them bile fools, you know, sort of crapping on the biofuel movement. And then talking about
solar and saying this was going to be the flight of Icarus and that if history didn't repeat, it rhymed,
the closest analogy to solar was going to be global crossing, which if you remember in the late 90s,
hype got high, cost of capital got low, hundreds of companies got funded, thousands of miles of
dark fiber optic cable got laid and lit, and the winner from all of that largesse was the
third world who ends up getting connected to the internet for free, and the losers are the first world
investors left hole in the back. So we look at all this and we're like no to solar, no to biofuels,
and what's an area that nobody's looking at? And I become obsessed with nuclear. And I knew nothing
about nuclear, but I spent the next year looking at every part of the fuel cycle. We looked at
uranium miners, mostly hucksters and fraudsters in New Mexico and Nevada, by the way. We looked
at modular reactors, great for society, but too expensive tobacco. We looked at the service
businesses, and then we always point our turret and say, it's a very sophisticated two-word question
to figure out where our next thing is, what sucks? And the thing about nuclear that sucked
was what do you do with the waste? Because there were political issues and there were economic
issues, but the waste thing was a real technological problem. And it turns out that there are 104 domestic
reactors, there are 440 global reactors. There's a big market in commercial waste, but then there's
this huge market that nobody knew about, which was in defense cleanup, cleaning up nuclear
bomb-making materials from places like Hanford and Savannah River and Idaho National Labs that nobody
ever knew about. And every year, $6 billion, which was a quarter of the Department of Energy budget,
was going towards people like Bechtel and Floor, these giant engineering companies. So we said there's got to be a
better technological way to do this. And if you remember, you know, these things that I look for,
really high scientific and technical complexity and IP, and the labor scarcity, we end up starting a
company. We named it after Madam Curie, who discovered and would die from radiation, called a
curion, locked up all the best people, all the best technology, and set our turret on the idea
of cleaning up nuclear waste. And that was in 2010, a year later, 2011, earthquake, tsunami,
Fukushima disaster, and we became the only company picked for the cleanup. And we went from a
million in revenue. Oh, and by the way, this thing was capitalized with less than $3 million.
And that's the only money that this thing would ever raise.
Total negative black swan in Japan. Total positive black swan for this little company.
And we went from a million to $40, $160 million of revenue, $40 million of EBITDA, sold it for
10 times to Violia. And it all started as just this crazy idea in a conference room.
And I became obsessed with nuclear. A few years ago, I became obsessed with this crazy area of physics
called metamaterials. Metamaterials are materials that were synthetically invented.
that have a negative index of refraction.
There's a glass of water in front of us.
If I put a pen in there and you look at it,
it looks like it sort of breaks in the water.
That's a positive index of refraction.
Negative index of a fraction.
Wavings bend around objects.
So the media goes crazy about this.
BBC especially.
Harry Potter cloaks are here.
Invisibility is real.
Okay, it's not.
But I go and start talking to all the scientists
that are developing this thinking,
okay, you can beam steer things like satellite antennas
without moving parts.
And you can see a world where you're going to have broad internet everywhere,
beamed down by satellite,
but you need antennas
that don't have moving parts. So I go to the scientists and they say, good news and bad news,
good news is it's real and this stuff is working. The bad news is Nathan Merveld, who used to be
the CTO at Microsoft and starts this firm called Intellectual Ventures, has locked up all of our
patents. And I say, oh, no. So I go to see Nathan and I say, hey, I want to start a company in the
space. And I've got a CEO lined up, but I've got customers lined up and we've got money lined up.
And he says, good news and bad news. The good news is your financing risk is really low.
The bad news is Bill Gates wants to fund the entire thing himself. I throw a tantrum, kick in
scream, work my way into the deal, and in a surreal stroke, the board becomes me, Bill Gates,
Nathan Murbold, and the founding CEO. And it was the only other board that Bill was on besides
Berkshire and Microsoft. And that was five, six years ago. We've since then three or four other
companies with Bill. And what's amazing, going back to that 100-0-100 phenomenon, I'm in a boardroom
in Bill's office, and we're making these antennas for satellites. And then I hear about these
young guys in San Francisco who want to take these satellite antennas and put them on these
tiny satellites. I knew nothing about these guys. We run and go see them. We end up investing.
I don't know where this is going. Orbital Insight. That would be the tertiary one,
but the secondary one was this company at the time called Cosmogia, then Planet Labs, now Planet.
Planet is making satellites that look like loaves of bread. And you launch them up into space.
We invest right before they did their first launch, and then they did 31 satellites, I think,
in their first launch. Now we've got about 200 plus that are circulating the Earth. It's the largest
constellation of Earth imaging satellites in history.
And it's amazing. So from this crazy idea in Metamaterials, it leads to this company with Bill Gates,
which leads to an insight in a boardroom that sends us on a hunt to San Francisco. We fund these satellite
guys, and then we get the insight, which is exactly what you just said, Orbital Insight,
which was an entrepreneur who said over time some of these images might become commodity,
and the real value is going to be doing the temporal analytical analysis that you can say,
okay, here's parking lots, or here's the shadows cast on oil tankers as a proxy for their carrying capacity,
or here's a caravan of trucks in China.
Are they going to a ghost town residential facility?
Or are they going to a productive chemical facility?
And that information was legal espionage that was valuable to corporations, to governments,
hedge funds.
And so we fund this guy, Jimmy Crawford.
Jimmy is, you know, amazing.
Build the AI for the Mars rover, ran Google books, went to Climate Corporate sold to
Monsanto for a billion.
So us and Sequoia fund him.
Bloomberg and Google come in.
And none of that.
A priori was knowable.
Something that started literally reading scientific publication in proceedings in the National Academy of Science or Science or Nature that leads to Bill Gates, that leads to Planet Labs, that leads to orbital.
Another example like that, my partner, Shaheen, who is psychotically obsessed with cars.
I hate driving.
My wife, we have a car.
She loves driving.
For me, it's an anchor.
It's just the time, right?
We talk about allocation of time and cash to spend attention on a road.
I cannot wait for, you know.
Pure self-driving.
I mean, it's just the faster that it comes, right, the more time I have to read and talk.
So Shaheen is obsessed with cars. And we're following all the stuff that's going on early in autonomous
vehicles from Google and Uber and Tesla. And he finds these two guys. And these two guys claim that they're
going to, you know, take on this market. And we think they're crazy. There's no way. And you meet
them. And it's like Steve Jobs and Wozniak. You've got one who's this amazing orator,
narrative storyteller and the vision, and one who's a technical genius. And this is Tim and Jesse,
who are the founders of a company called Zooks. Secretive Facility up on Slack, the Stanford
for linear accelerator corp.
Us and another venture firm fund them very early on.
And we, at this point, I think, had $25 million in the company.
Fast forward a little bit.
And I'm in a room that's the size of an average conference room.
And there's 20 people in there that look like they're playing video games.
And I'm like, what the hell are these guys doing?
And these guys turned to me and say, you don't understand.
Outside the vehicles, which don't even look like cars,
they are ingesting from optics and LIDAR and radar and vibrational sensors,
and thermal sensors, all this data and information, and they are processing it at the rate of
one second per second, what we call reality. And they are doing thousands of simulations a second,
and they're doing it on these crazy new GPUs. And so I say, well, what do you mean? And they said,
well, those two guys are from Nvidia in the corner, and we've got chips that aren't even on
the market yet. So I tell all my LPs and our hedge fund friends, like Nvidia, right? This is like three,
four years ago. And Nvidia takes off because the narrative changed from this being a gaming chip
company to being the sole of the new machine for AI and machine learning. Then we go and say, okay,
what's the next invidia? Who's the next group of people that are developing GPUs? And we go and find
these guys run by Naveen Rao at a company called Nirvana. And we fund them. Now, not even a dollar
in revenue and barely a product on the market. And I'm out there publicly talking smack about
Intel and how they're a company in secular decline. And Intel buys them for $400 million.
None of that was knowable beforehand. And so it's being paranoid and curious and ambitious when
you're in a company that is at the cutting edge that leads you to the next.
And so that's why I get the confidence that I know will be investing in crazy things for years to
come. And I can't tell you possibly what they are today. Yeah, it all sounds like your answer,
which is better than most, to what is your edge, right? And you sort of build up this,
this internal network effect, the relationships and the momentum that you seem to have just as a person,
but also probably as a firm, just kind of worming your way through deals. From the LP's perspective,
I'm very curious how this works because you do so many different things,
underwritten probably very different ways, you know, underwriting a person and a founding team
versus a later stage technology versus a hard science thing versus originating a company.
I mean, this is a really interesting mix.
How does that work with your LPs?
Are they just kind of betting on Lux in general or are they differentially betting on,
you know, and themselves underwriting like different expected risk return profiles of these
different buckets?
I'm fascinated about how this might work.
No, I think that they're betting on a philosophy that is manifest in a different set
of personalities within the firm. But at root, it is people that are thinking a little bit differently.
In fact, all the people that invested with us over the years and all the people who rejected us
over the years did it for the exact same reason. They're like, you guys are sort of different.
They couldn't bucket us as IT investors. They couldn't bucket us as biotech investors. We weren't
seed stage people. We weren't growth equity guys. And they just said, you guys are just sort of
different. And so it's interesting because we are always on this sort of treadmill. It's sort of
the Red Queen theory that you have to run twice as fast just to stay in place. And things that we
were investing in a few years ago are very hot today. And this is if we're successful, exactly
what should be happening. It's the four or five-year psychological bias that everybody wants
to be invested today where they should have been four or five years ago. So four or five years
ago, we were in AI and machine learning and robotics and satellites and autonomous vehicles. And
today, we have to be careful because I always say funnel-wide and filter high. We don't want to
be the firm in 98 or 99 that is like, geez, who needs another search engine to miss Google?
But at the same time, the incremental bar to make an incremental investment in those spaces is very
high. And now the kinds of stuff that we're looking at are things that for the most part
nobody's talking about. One that we just recently did, maybe there's one or two investments
that people have made in the venture world in the space, but tattoos, tattoo technology. We looked
around, said what sucks. 40 million Americans have tattoos. I joke that generally when you get a
tattoo, you are a long regret and at some point want to reverse that trade. The asymmetry to get a
tattoo, 60 bucks for a small Celtic tattoo, $6,000 with $10,600 laser treatments to get it. So you look
at that, you say, there's this really interesting market. And by the way, just sort of memetic
cultural copying, huge prevalence, particularly where I grew up in Coney Island Brooklyn, of African-American
Latinos that have mirrored basketball players, rappers, full body, arm-length tattoos. You can't get
laser treatment because if you do, you're bleaching your skin white. So we've been looking for
three years to find, and we found a ton of technologies, but the missing piece was finding the
entrepreneur that could take paternity or maternity and run with it. We finally find this guy,
Errol Damlin's successful UK entrepreneur, us and another venture firm fund him. He found
the same Princeton professor that we did at the same time that's doing femtosecond lasers
to remove every wavelength totally painlessly. And I'm convinced that if you can get the removal part,
then you can come up with new technologies for application because it is a timeless form of human expression.
And you'd be amazed how many of our conservative LPs say, if I could have something longer than temporary but shorter than permanent, I would get one.
And so, you know, that's a funky area that people are not like tattoo technology.
Have you met the guys from Coventure, Ali.
Oh, I love Ollie.
Yeah.
I've been a fan since right before he started that fur.
Yeah, when we talked, I was just talking to him recently about rolling up tattoo parlors and basically parlaying some tattoo artist brand into a national chain, which
doesn't exist. This could be the extension of it. This could be the extension. I love it.
So we're going to spend more time on thesis-driven because I know that's the area that you're
especially passionate about. But I would love to spend a minute or two on the earlier stage
business where it's really more about betting on people. Specifically, I love this idea of what sucks.
And a guy here in New York City, Alex Mozad, who was also on the podcast who wrote a book about
platform business models. The litmus test he had was like, what's a X, no longer a pain in the
ass was his way of formulating it. That's a good one. So I would love to hear about
how you evaluate people and their ideas when it's very, you know, very early seed stage
PowerPoint level. So I would say we get this roughly right. And we are always fine-tuning,
and it's actually led to a change in our investment process because of sometimes us getting
it very wrong, it being our evaluation of people. There are amazing, credible people,
and there are amazing salesmen. And sometimes those two people are one. And when they are,
you have an amazing entrepreneur. But oftentimes they're not. And we've had incredible
execute your operators, people that get stiff done. They come up with a plan, they're executing it,
but they cannot go out and raise money. They can't recruit. They can't sell a story. They can't talk
to the media. And that is a major deficit. On the other hand, you have people who are amazing
at telling stories, and they can lower the cost of capital because they can raise expectations,
but they can't execute. And so you need a marriage of both. You need the storyteller,
and you need the executor and the operator. When we're assessing somebody, it's interesting
because we really try to consider ourselves as contrarian.
So we're trying to think, what is everybody else in the venture world thinking about
and what can we think about it in a slightly different way?
Yet, we've realized at a meta level, how hypocritical we are,
when we have a complete consensus internally around something.
And almost all of our mistakes are when an entrepreneur comes in.
And we are so impressed with Shire He.
Everybody is looking around the table.
We're trying not to let people know.
In fact, one of my partners used to call this the Pampers effect
because you're so excited.
You're like just trying to keep it cool and not
convey how badly you want to fund them. So you have some negotiating leverage. But we're sitting
around the table. We're looking at this part. We're looking at each other. We know we want to fund them.
But what are we reacting to? We're reacting to their persuasive ability to tell the story. We haven't observed
their ability to operate. We haven't observed their ability to recruit. We're convinced that they can get
us to part with our money. They probably can get other investors to part there with their money.
So financing risk is low. But all the other risks are huge. Technical risk, market risk,
product risk. In fact, it's interesting because there's a dichotomy in our partnership in optimism
and pessimism. My partner, Peter, is the perennial optimist. He will look at a company and say,
you know, how can this be a billion dollar business and what are the assets and the tools and
the resources that Lux can bear to make it so? Who can we populate the syndicate and the board
and who can we get the media to cover and all the positive things. And I've got a quote that says
failure comes from a failure to imagine failure. So if you can imagine all the things that can go
wrong, then you can flick them off the table. Because I think of it almost like the first law
thermodynamics, like energy is not created or destroyed. Risk and value just change form. Technology risk,
product risk, market risk, financing, all those things are risks. I kill one of those risks
with time or talent put into it. If you're a subsequent investor, you should be paying a higher
price and demanding a lower quantum of return because you're taking a low quantum of risk.
So when this entrepreneur comes in and is pitching us, maybe they've eliminated the financing
risk, but all those other things exist. And so the biggest mistakes we've made have been when
an entrepreneur comes in, we won't let them leave. We want to give them terms almost on the spot.
The best performing companies we've had, conversely, are when everybody on the firm disagrees,
except for one person. So one person is the passionate table pounder. And they're like,
I'm telling you, she's got it or he's got it. We got to do this. And everybody else is like,
I just don't see it. And that is usually the best performing company when we do that.
Why do you think that is? I've heard this a number of times from firms of all types, public market,
private market, et cetera, that high levels of disagreement, which makes sense in like from a value
investor's mindset, you know, you need a consensus to be very wrong to get a mispricing typically,
and certainly in public markets, but probably in private markets too. So maybe say a little bit
more about why you think that is the case, that it's the minority opinion that tends to lead
to the best outcomes. Well, I think it is, on the one hand, somebody is seeing something that
everybody else isn't. And even though, again, within the firm, against the rest of the world,
we consider ourselves as different thinkers. But then when you see consensus here, you've got to say
something's wrong. So some firms actually implement like a devil's advocate or a red corner person to
actively do that. It's much better when it comes naturally. And now, certain people have that
disposition where they're naturally argumentative or debated, but I just think it's somebody seeing
something and feeling so passionate about it that in a sense, we have confidence that they are going
to be obsessed in making this a success. They're putting their brand on the line. They're putting
their reputation on the line. And by the way, we allow people to get one of those in a fund. And the reason is
really, it's almost like a Josh rule, because I can be.
pretty persuasive in a strong table pounder. And if I did that all the time, I would abuse the
process. So I really have to think about what's the silver bullet that I'm going to really pound
my table. I basically get one of those in a fund, as does everybody else. So I just think it's that
phenomenon that you're looking for that contrary view, seeing something that somebody else doesn't,
and then doubling down with your personal passion to like make it so. They're the best outcomes.
Why do you only get one in the fund? Well, again, it's to avoid the abuse of the process.
Because if you have a partnership, we don't really rule by democracy. At the end, it's Pete and I make a
final decision. But I would be table pounding every time for every deal I wanted to do. And, you know,
this way I sort of have to treat it as a scarce and really valuable thing. What's a particularly
memorable, maybe recent experience with a founder that really stood out that kind of fits this
mold that you're talking about? I don't want to name names, but there was one where they came in.
We literally wouldn't let them leave. We offered them terms on the spot. It was a particular
product that all of us wanted to use. It was a future that we wanted to live in. We very quickly
realized after the investment was made that this person, as impressive as they were, had no
intentions to step aside and bring in a real CEO, and they were really not qualified to do it.
They had a family member involved.
I mean, it was sort of like a failure of diligence on our part.
And it turns out the company is doing really well.
And we've had some situations where process versus outcome, the outcome may be extraordinary
for our investors, but process, we consider a total failure.
We got it wrong.
Our assessment was wrong.
And so I think that has warned us, like, if we're too excited.
about the entrepreneur, you know, rein it in a little bit because something's off.
Let's talk about thesis-driven now. This is something we really haven't explored at all.
Most of the venture capitals that I've talked to have been earlier stage, probably mostly
seed stage, and it really is about betting on founders and maybe on ideas and maybe a little bit
on markets. I talked to Annie Rackleff about, you know, addressable markets and things like that.
But talk about this thesis-driven approach to private investing, maybe using some examples.
So Curion is a great example of that just because, you know, you're reading voraciously,
you're understanding what's the consensus, and then you find that very in percent.
And so nuclear was something that nobody else was thinking about. The same thing. We had a thesis around
vaccines a long time ago, in part because it was totally contrary. And you go to a farm a day where,
you know, Merks and Pfizer's host a day and the VCs come in. And they would say, this is our wish list,
and these are the do not call list. And on the top of the do not call list was vaccines. And so we sit
there and say, well, the pendulum is going to swing. There's going to be a reversion back,
because the thing that's not wanted today is going to end up becoming scarce. And so let's go
and populate the very best, a company with the very best IP and people. And we ended up starting
company taking that public in the vaccine space. Robotic surgery. You've got one mega giant in
intuitive surgical. It has been a battleground between longs and shorts, but whether it's $20, 30 billion
market cap. And we end up finding the founder of that. And he's looking at the scope of technologies
that are out there now and the computational ability to map inside of the body and all these new
tools. And we say, okay, like this is going to be the future of medicine. And instead of having one
modality where you're just focused on hysterectomies or prostatectomies in the urology department, you could
have these robots that are modular in an ER doing 20 different surgeries. And so that was a thesis around
robotic surgery. There's, you know, the thesis around the scientific evolution of something like
metamaterials, tattoo was a thesis. We have a thesis that we haven't executed in a substantive way yet
around hearing where you just see the demographic loss from people wearing headphones and aging,
that there is an opportunity both for therapeutic and devices on the hearing aid side,
something novel. And then I can share two that are sort of crazy. I love crazy. Okay. So,
And by the way, I tell my LPs, because we share these ideas.
I sort of subscribe to the idea that if any idea is really good, you sort of have to shove it down people's throats.
You don't have to worry about people stealing it.
So one idea is really two phenomena.
One is technological, and one is in moral philosophy, and I think that they're combining.
And I tell my LPs the idea, and I preface it, you're either going to think this is a multi-billion dollar idea,
or you're going to think it's bad shit crazy.
And if they think it's both, then I know I'm onto something.
But particularly if people are like, that's a little bit too weird for me.
I know I'm on to something. So technologically, we have better signal processing than ever before.
High frequency sound, low frequency sound, vibration, gesture, motion, anything that you can imagine,
the modalities that we have to input into a machine are greater than ever before. Okay, and that's
for two-legged mammals, but I think it will hold for others. Second, moral philosophy, Peter Singer's
sense of an expanding arc of moral empathy and inclusiveness. I am not an animal rights person. I am
not, you know, super left-leaning, although some of the people in the firm are. I like bacon. I like beef.
if I like burgers, but you can observe, and it is always better to make observations and predictions,
that there's this zeitgeist around animal rights. And so the evidence for this,
Shamu out of sea world, ringling brothers before they went out, elephants were gone, talk of the
horses in Central Park being gone, Vietnam outlaws eating cat. China went from middle class that was
eating dog to widespread ownership. Anybody post a picture online hunting, they are instantly shamed.
And so you put these two things together, and I am absolutely convinced that within 10 years,
people will look back and say, my God, how did that never exist?
Where that is a series of beautifully, aesthetically designed devices, Apple-like, for the pet
owner, where probably for dogs to start, animals are able to express choice, preference,
and control.
I want chicken or beef or fish.
I want to go to the park or the zoo, or I love you, or I hate you, or leave me alone.
And obviously, this is not going to be like Pixar's Up movie, you know, with a dogs,
talking collars.
But just I have to believe that the intellectual and emotional,
life of animals is greater than them nuzzling up against you and barking at the door and pawing
at it, you know, to get out. So what I've been doing here is talking to the very best people in animal
cognition and communication and corraling them and then talking to hardware designers and thinking
about what are the kinds of modalities that this might be so that you could basically crudely
communicate with animals. That's a crazy thesis. Another one, and this one is something that I'm
really excited about and where I'm spending a substantive amount of my time at the moment. And again,
and I know it because everybody's telling me shut up already about this thing.
There's a trend through the history of technology
where something that was invented for a minority group, people with disabilities,
ends up giving them the ability to go from disabled to abled,
and then that same technological capability takes people from abled,
in a sense, to superhuman or superpowered.
And you can look at every sense that the human has and find an example.
In eyesight, people that were visually impaired,
it led to the technology of optics and ultimately to telescopes and microscopes.
people who could not speak when you had speech to text, and Stephen Hawking is a great example of this.
That technology would lead to things like speak and spell and to voice recognition and all the series and Alexis that we have today.
Exoskeletons for paraplegics are being used by the military to create sort of these super soldiers.
And so you can look at all these external peripheral devices and imagine how we've gone from disabled to abled and then from abled to superhuman.
Then I started looking at the biotech and genetics piece of this.
And here's the crazy thing.
I always say that sci-fi and sci-fact are sort of shrinking, that gap between that which was once imagined and that which is real keeps getting closer and closer.
And there's endless examples within the Lux portfolio of something where the founder or us were inspired by something we read in a graphic novel or saw in sci-fi.
And it was fiction, but now it's real.
Professor X in X-Men dons this cognos helmet and from a population of a billion people is able to find the mutants.
Now those mutants are shooting lasers out of their eyes and conjuring fire from their fingers, and that's absurd.
But think about this, that if there are a one in a billion chance of some rare genetic condition,
and there's 7 billion people on the earth, then there's probably 6 or 7 people walking the earth
that have some really unique trait.
That could be a super high threshold of tolerance for pain or super low threshold tolerance of pain.
It could be somebody that can withstand heat or cold abnormally.
It could be somebody that needs very little sleep, somebody that has high metabolism,
somebody that has acute hearing or can see in the dark.
people with hyperthygia who can go back 50 years and recount the most acute detail of a single
moment of a day. People with muscle hypertrophy who at a young age looked like their bodybuilders.
Well, if you take that and you can almost Indiana Jones style have a group of people that are gene hunting,
trying to find these unique individuals in the same way that the NBA scouts are trying to find
the seven-foot eight person in China, I think that these people exist, probably through anecdotes
and local newspapers and stories and family history. But you start with that, you sequence some of these people,
start using the basis of the extraction of the genetic information for benevolent good.
Start with therapeutic purpose. Take rare orphan diseases, people with low muscle tone, and give them
high muscle tone. But you can see the direction in China and where things are going, where they
have less ethical considerations and regulatory apparatus. And you can see a world of human
enhancement and augmentation enabled by this. So those are two feces that this year we will
probably start nukos in, one around animal cognition and communication and really having a
jurisdictional line between what's real and what's BS in the science and the other of looking for
these X-Men. Who are these rare mutants? And what can you genetically engineer to make people better?
I'm really curious about the learning process behind one of these, one of these these
theseses. So this is something I've been kind of refining over the years. There's books,
there's podcasts, there's conversations like this one. There's source material and raw data.
What's kind of your process for feeling your way through a topic? And it could be one of those two
or anything else. So on this X-Men superhero one right now, literally, the past 10 days, I've probably had
30 calls. 30 calls with people that I know who are Nobel laureates, people that I know that are
CEOs of our existing companies. And every one of those people, and I keep actually like a physical
star map of this, I happen to use a program called poplet that I just, you know, start populating these
things with. I've never heard of that. It's like a connected diagram. It's not particularly good,
but I've been using it for years. And I just start to see the visual connections of who's connecting
me to who and what tidbit they're having. And it daisy chains. So I speak to somebody like, you know who you
should talk to is this person. And then that person tells me, no, actually the person that you just
told me that you spoke to, like, you know, in this other, yeah, they're sort of full of it, right?
And so I start to get the veracity of who's for real and who's not. And in this process,
I'm stimulating their thinking. They're on a plane. They're like, oh, you know, actually,
I just met somebody. I should introduce to Josh. And so I just, I activate the network.
And information is coming back to me. Introductions are coming. And it'll probably be a six-month
learning process. It was the exact same thing with nuclear. It was the same thing with vaccines,
same thing with robotic surgery, same thing with metamaterials. And it's just, you know, we have the
passion, we have the excitement to do the work, and sometimes you come back and you get disconfirming
evidence. Somebody says, it's a really great idea, and it sounds like a great story, but the science isn't
there yet. And, you know, those are frustrating, right? Because they end up on the cutting room floor.
But that's the process, just, you know, going back to that idea of randomness and optionality,
you're talking to everybody, collecting and processing the information, running it down to
ground truth. And in the process, you're also recruiting people. So, you know, I might talk
to four scientists and convince, okay, I have to get them all involved in this. And I might talk
to somebody else and be like, oh, my God, this guy's amazing. I need to get them
on the board. And in the meantime, I have investors who are like, oh, when you do that, I want to fund it,
right? So every one of those risks I'm thinking about, how do I kill those risks? So I'm going to try
to corral a lot of those ideas into the next question. You mentioned basically finding X-Men.
I just started this new book on CRISPR and kind of gene splicing. And I'm always fascinated with
uncertainty in blind spots. So biotechnology is actually a great example in my world where the
outcomes tend to be so binary. I don't want to plant the axiom that people can consistently do
qualitative analysis to pick the next best biotech stocks. I don't know if that's possible,
but I know that it's basically impossible to do it quantitatively. So there are just these kind of
certain pockets of industries or opportunities that are very hard to get right. So I'm curious
how you think about like the exposure to uncertainty and this idea. You mentioned this idea last
night when we were chatting back and forth about rebel scientists. Maybe go into that notion of
rebel scientists and how you account for stuff like this where it just seems like impossible to predict
what's going to happen. It is totally impossible to predict. And so on the biotech side, by the way,
biotech actually is seemingly rational in that. Most of the companies end up valued in the phase two,
sort of pre-phase three, at 200 to 300 million. And you could almost say, well, okay, if there's a 10% chance
that this is going to be a $3 billion, expected value is 10% times $3 billion to $300 million.
And so you sort of end up around that phase. And so if you look at the pipeline of what are the
underlying base rate odds of a compound progressing from pre-clinical to phase one to phase two,
A, A, B, phase three, actually getting approved, you can sort of see that probability. It's like a funnel.
But I think that betting on a single, you have no idea how it's going to turn out and what
the adverse indications are going to be and what the toxicity is going to be.
And so you have to have, in my view, a platform.
It's a portfolio.
So we've never really had a single drug biotech.
There are people that get lucky and post-factor like, oh, we knew it all along.
And I say BS.
But I think you have to have in something like biotech and even in some of the hardcore really
early stage science, a portfolio of these things so that you have multiple shots on goal,
you're not betting the farm on one.
And you have to have investors and a management team that can totally embrace that.
you have multiple horses that are sort of, you know, running at the same time to make some metaphors.
On the rebel scientist part, this to me just gives you a higher probability that somebody is thinking really differently.
And typically this is somebody who's coming from outside the field.
I mean, I'll give you a great example.
Somebody you should probably have on the podcast, Martin Rothblatt, fascinating friend who,
Martin was Martin, founded Sirius XM satellite radio.
And, you know, now transgendered, but married to the same woman for 30 plus years and multiple kids and knew nothing about biology.
and had a daughter who was afflicted with pulmonary hypertension and ends up going and identifying a compound in Welcome Trust in GSK that is totally improbable.
They say you'll never be able to formulate it, it'll never work in humans.
She literally is picking up a high school biology book and teaching herself and then surrounding herself with a problem, but total outsider, right, in every facet, every definition of it, and ends up with a drug that works.
And today it's a billion and a half dollars of revenue.
She pays GSK every year 150 million bucks, 10% royalty.
and it's a $6 billion publicly traded company.
And so that's the kind of outsider that looks at something and whereas most people are like,
oh, that'll never work.
And you always hear that from older entrepreneurs and older executives.
The young people are really naive.
Stan Druck and Miller, famous macro guy, was one of my early investors.
I remember Stan saying for the same reason he was investing in us.
It wasn't because we were smart.
It was the same reason that somebody gave him money when he was early,
which was the same reason that they put 19-year-olds on the front line of war.
They don't know any better than to charge full speed ahead.
You want a little bit of that entrepreneurial naivete, and sometimes that comes from an outsider
who doesn't know all the dogma inside of a sector.
So we love the rebel scientists that generally have something, and by the way, my favorite
entrepreneur back is somebody that is sort of like me in a way.
They have something broken, something from their family, something from a divorced background.
They were made fun of as a kid.
They had a lisp.
They were fat.
It doesn't matter how much money or success they achieved.
There's always that empty sort of hole inside.
And I have so many LPs that actually have been attracted to invest with us because they themselves were like those people.
And it's just something that is this perennial, inextinguishable fire that drives these people through their life.
And some of the great entrepreneurs, you know, maybe they were adopted, maybe they were orphans, they were made fun of.
They had some affliction.
They were dyslexic.
But there was something that was driving them and it was usually against the masses.
And so whether they were rebelling against what was around them or people or resentment, you know, I have a lot of debates with people about like, oh, you should be, you know, have this great.
positive energy, I think that amazing things happen with negative energy, with dissatisfaction.
Because by definition, if you're happy, you're complacent. It's good to find calm and peace,
but if you want change and progress, somebody's got to look at something and literally go back
to those two words and say, what sucks? That sucks. And then you have to be motivated to want to change
it. And I think that comes from like this negative energy. And usually you find that in these rebel
scientists. Do you think maybe this could even be within Locke's younger analysts or something that
you've educated or mentored or what have you, that this kind of rebellious minds.
set can be cultivated in the absence of just like genetics or early experience, some negative
early experience? Is it something that like the average Joe can work on and improve upon? Or is it
kind of baked in? I don't want to say no. It would be naive and maybe ignorant, but I haven't
seen it. People that are generally born in good circumstances, people that generally don't have
scarcity, people that don't grow up wanting. I just, I haven't found that same kind of grit.
So yeah, it's possible somebody gets inspired and reads. But when you know, I was driven,
I didn't want to be poor.
I wanted to find a great partner in life.
I wanted to make my mom proud.
I wanted to say all the naysayers who didn't believe in me and shut them down and prove them wrong.
And I just, I've never personally found that somebody who grew up extremely wealthy, without adversity, without hardship,
without somebody telling them that they couldn't do something, that they had that same kind of flame and fire.
I mean, look, Bill Gates was, you know, a brilliant guy.
He didn't grow up poor.
But he still had this sort of competitive edge, right?
I mean, it was like the revenge of the nerds.
And I just, I think it's possible, but it's rare.
Curse who some of the other investors are that you've learned the most from?
It's pretty rangy.
So my best learnings have been on boards and seeing how people behave.
And these are typically older.
So I generally believe for entrepreneurs, experience is overrated.
Everybody's like, you know, get experience.
And you look at some of the most amazing entrepreneurs in history.
They had no experience doing what they did when they started, none.
They were either pioneering some field, but they had the gusto, and they often knew to surround
themselves with good people.
On the investor side, you know, there's a guy Leighton Reed, a long-time venture guy.
I've been on a few boards with him, and he had a style of equanimity and professionalism.
He could get to the 90-10 of what mattered.
He was able to drop his voice a little bit, you know, an octave or two to command a baritone
attention when you needed it.
He would support the entrepreneur and develop the trusting relationship with him.
There was another guy, Chris Brody, who a long-time VC, Warburg-Pinkus, also, like, you know, very
fastidious when it came to the analytics and KPIs for a business.
I mean, hold people really accountable.
So he was another one.
There was somebody else that was just super inspiring as a coach for entrepreneurs.
So they never really beat him up in the board meeting, but they were always, you know,
really inspiring and they always brought out the very best in them.
By the way, Bill Gates, in a boardroom with a CEO, you'd think he's beating.
him up and he's going to be the smartest guy. And if somebody else is beating up the CEO,
he's the first one to defend him and be like, I actually think he's doing an amazing job.
He's able to step back and be like, okay, this is the one thing that really matters. And I find
that super impressive. But our number one job on the board is making sure that she or he, whoever
is running the company, are doing a good job. And if they are, I basically view it as we work for
them. And if they're not, then we have to replace them. And that's the hard thing. And you can
never do that too soon. How do you think about investing outside of your particular company,
owner asset class. I'm going to start asking people this question more and more because it's a
question I'm asking myself. The vast, vast majority of my invested net worth is in public markets,
quantitative equity strategies. And I think that will always be the case because that's what I know.
That's what I can have the discipline to stick with because I know it so deeply. But I want to explore,
and obviously podcast is good evidence of this, other areas. I'm curious how you think about that.
So, you know, leverage buyouts or public equities or credit or, you know, things that are not what you do in your day job.
How do you think about those, not only has the potential to learn about them, do you spend time on them, and do you personally allocate capital to them?
I do personally allocate capital, and my wife is an activist public market investor.
Interesting.
So she does the public stuff and I do the private stuff.
I will say I'm more a student of business and history and human nature.
And so where that affects asset classes, you know, I get it.
Credit is a little bit harder for me.
It's more structured.
It's more finance.
It's less about the human psychology.
Real estate is totally uninteresting to me, although, you know, we have some, you know, personal investments.
but I'm more interested in public and private markets because on the one hand you have
true businesses that you can understand and then you have human psychology.
And so you can look at everything from, and I'm obsessed with the rational capital allocators,
whether that's the Rails Brothers or Buffett and Malone or Bezos and, you know, people talk about
in technology.
Amazon and Jeff Bezos and Elon Musk and Tesla in the same breath.
And, you know, if you follow me on Twitter, you know I'm crazy about this.
Elon is a brilliant guy.
SpaceX, incredible company.
Tesla, not so much.
And it's like heresy in the venture world for me to say that.
Jeff Bezos raised money in an IPO, never raised additional capital.
Incredible.
And people say, well, he had no profits and, well, where did all that value come from?
It came from cash generated in the business.
And the same way John Malone did, he didn't report gap profits.
So having an understanding of business and understanding accounting and understanding human nature and good capital allocation,
I don't think it matters whether there's liquidity, which is to say whether they're private or public businesses.
But businesses, people that are corraling capital, producing a product, serving a market to me is just endlessly fascinating.
I also have a pension, which is my personality, for identifying fads and frauds and technological obsolescence.
And I am part of a sort of private group of people that are always looking for great short ideas.
And it's interesting because Lux is fundamentally shaped like a call option.
The stuff we do are low probability, potentially high magnitude outcomes.
you know, there's a few ways to cut a venture fund, but on average, a third year companies are going to be total zeros, and you don't know which a prior.
A third, you might bank your money back, and a third maybe you get 10x. You end up with a 3x cash on cash fund.
Another way to look at it is maybe you have one or two companies that return the entire fund once, maybe two to five next companies return in another time and everything else combined return a third.
You get 3x in 10 years.
But that's a call option like payoff, and I look at this and say, okay, the put option like payoff, we're betting on the future.
but maybe there's an opportunity to bet against the past.
And so that's an area that I'm interested in increasingly of saying,
you know who these fads, you know who the frauds,
you know who the crappy companies that your venture peers have taken public,
you know the bad operators, and just being students of business and markets.
And again, that curiosity, which is the same curiosity you have,
to talk to interesting people and learn about different asset classes, you know, can help get you there.
You mentioned your partner was the optimist.
You're the one focused on kind of the downside and risk.
So let's use that to talk about the short idea,
the put option part, a little bit more.
don't necessarily have to name individual shorts or whatever, but I'm curious about the process
behind this and how that maybe small group, that private small group was sort of cultivated.
What are you looking for? What's kind of the inverse of what you look for on the call side,
on the put side? It's just really bad businesses. Identified how, I guess that's the question.
Terrible unit economics, massive amount of leverage, and particularly run by people,
which are horribly promotional and dishonest. Because I think, you know, sort of those things like
if you lie to people in the public, you're going to lie to yourself in private.
And I grew up in Coney Island. There were carney barkers and hustlers and con men. And so I always grew up,
you just grew up skeptical, right? You're like, you don't make eye contact. And if you do, it's sort of like
half squinted, like, what's that guy's agenda? What's the game he's running? And so I'm generally
skeptical of people and more distrusting. Thankfully, there are people here who are more trusting and open and
haven't had those same kind of life experiences. But you can see it. You can see these hustlers.
And you just want to avoid them. So on the short side, I'm fascinated by, you know, these crazy promoters,
which, by the way, it's really dangerous because one of the greatest assets, and we talked about
this before about on the venture side.
Fundraising.
Fundraising.
And so if somebody, I would never short a religion.
And some of these people are like the Joel Austines of public markets, right?
It's just like they get out there.
They can promote.
They're selling.
And like I always say, Elon doesn't sell cars.
He sells a future.
And he does an amazing, admirable, enviable job that people should take note of.
But the fundamentals of that business are just not good.
It's not a good business.
You said SpaceX is a good business.
So maybe contrast SpaceX and Tesla.
I'd be curious about your opinion here.
It's interesting because I don't actually know if it's a good business,
but what it lacks is the need to publicly promote to raise money
in the same way that is needed amongst management with Tesla.
And so I'm a continued awe that SpaceX keeps low expectations.
You know, you'll even hear Alon sort of tempering like, look,
this thing might blow up, right?
It might be a total disaster.
And then it creates awe and amazement.
I have a crazy speculative theory, and it's a complete speculation.
and you can discount it as totally absurd.
But I'm convinced that Tesla and SpaceX will actually end up merging,
that the narrative is, it's a beautiful, simple narrative,
which is from space and back to space.
So you've got from the sun, which goes down to Solar City,
and then terrestrial, and you've got the boring company,
and you've got Tesla, and then back up to space through SpaceX,
and it'll just be called X.
And if you look, you know, a year or two ago,
he bought that domain name, X.com.
And so I think that that is the ultimate way.
Now, the cynic would say maybe there's financial obfuscation and it's easy to do the same sort of thing you did with Solar City.
It's a little bit of a magic trick.
The optimist would say, like, what better way to attract capital in some of the brightest minds for the future of humanity?
This topic of unit economics has come up quite a bit.
And one of the topics I've been spending some time on privately is just sort of the evolution of business models and business in general, like going back to like Kosa's theory of the firm and the platform business we've spent a lot of time on on the podcast as well.
I'm curious how you think about approaching the quality of a business.
this unit economics way of doing it has become very popular, boiling things down into very simple terms.
Maybe you could describe that process. And more generally, I'm just curious on your take on the
evolution of business models and what matters in business. I'm really excited for Albert Wagner's
new book, I think it's called World Without Capital or Beyond Capital, something like that,
where he mentions the scarce resource used to be Capital. Now it's attention. So that may change
business models. I'm curious your take on that. Well, I actually think Capital will become scarce again.
But Albert and I are in a few investments and on some boards together, and he's wonderful, by the way.
I think the most important thing in business, and it's interesting because everybody at Lux has a different lens that they look at these things through.
And I always tell entrepreneurs, you know, when we're sort of asking them questions, most of my questions, most of the lens.
And after we make an investment, I insist that they start answering these questions.
But I am psychotic about competitive advantage.
What can you do or what can you assert that you can do that will scare competitors that nobody else can do?
From that flows good union economics.
So if you have a true moat of whatever kind, an unfair source of supply,
something on a brand, the ability to get scale where a competitor can't, a technological innovation
that somebody literally can't access, and they look at that and they say, it's not fair,
I can't make it that.
That is a beautiful thing.
From that, you have a moat.
From moat, you have pricing power.
You have monopsony like pricing leverage with suppliers.
I just, I think everything flows from competitive advantage.
So when you're doing the venture side of things, and you're thinking about that as part of the
assessment, how do you evaluate that?
How do you evaluate the potential for a moat?
obviously in many cases it's not there yet.
Well, the first thing that you can see is how many possible entrance are there in a space.
In fact, the scariest thing that I think people make the biggest mistake on is they look at, you know,
the trajectories of, you know, such and such market by 2020, whatever, is going to be this billion
dollars.
And they're always hockey sticks.
That is never predictive of returns, ever.
What is predictive of returns is how much capital is going into the sector.
The more capital that's going into the sector, that is the greater measure, the worse your returns are going to be.
And so, you know, I mentioned before I like to go where there's these five things and you have scarcity.
If there's 5,000 global competitors to group on, you are spraying and praying.
You have no idea.
Forget about 5,000.
If there's 500 or 50, how are you picking a winner?
And so I think you have to go where there's five or less companies.
And the conditions for those, those sort of barriers to entry, are the critical things.
Because otherwise, those guys are going to be competing for talent.
They're going to be competing for attention.
They're going to be competing for capital.
They're going to be competing for customer interest.
And the worst thing that you can have is not a bad product, a bad competitor.
Because if you're going to a customer and then you knock on the door and you get access to them,
and then somebody else was just there a week before and they were a really crappy competitor,
they've just completely ruined the opportunity for it.
You know what, we're good.
We don't need to look at this market right now.
And so I really think it all flows from competitive advantage.
What would be your assessment of where we are in kind of the venture capital landscape, broadly speaking?
This is a question about cycles. I think venture capital results tend to be quite cyclical,
but just generally your assessment of the industry, whether it's doing the right things,
whether it's structured the right way, any problems that you see with the venture capital business.
You know, I'll tell you that the average short seller, who I think is right, is always wrong on timing.
And my views have so far been wrong on timing, but I think that they are fundamentally right.
They were inspired actually by something that I was studying at Santa Fe Institute, which was the slime mold.
And slime mold was this single cellular organism that sort of becomes a superorganism.
When the environment is resource rich, the slime mold spawns off and tries every experiment.
And then when the proverbial stuff hits the fan, it recongeals into this mothership waiting to spore off again.
The analogy is when there's a widespread availability of capital.
Every experiment is being tried.
In fact, people have asked me, is it better for innovation and venture capital when the cost of capital is higher or low?
My answer is yes, it doesn't really matter. When the cost of capital is low, you get what you have now, which is the slime mold expanding, every experiment being tried. Evidence for this are the we works. The abundance of we work, and I was saying this two years ago, which means I was wrong because I was early, meant that every mom in Tribeca and every guy in Soho is starting a business, going into a we work, they have friends and family that maybe feel wealthy from stock gains, or maybe there's just bank money available, and they're starting companies.
So the slime mold is expanding out and every experiment is being tried.
All the kind of stuff is being thrown up against the wall.
Now, for society, 99% of those things are going to fail, go out of business, die.
But the detritus that ends up falling on the floor from the wall becomes the commentatorial fodder for the next thing.
That happened in the internet boom.
It happened in every boom in history.
And so that's the good news.
Conversely, if you had, you know, back like in the 70s, 15% interest rates, then capital is super scarce.
Only the very best people and very best projects get funded.
You know, that was a time when you had FedEx and Microsoft and other companies that emerged that became these timeless entities.
And there, you know, necessities the mother of invention.
Capital is scarce.
And so I don't think it matters.
The current environment, cash is abundant.
It is everywhere.
Corporate VC.
So here are signs, you know, I started this little neologism on Twitter.
I call notum as a not a bottom.
Signs of excess that are worth taking note because you should be scared.
I can tell you that our pace of investing is way slower today than it was two years ago.
go. And it's slower because prices are crazy in markets. And I worry that the amount of capital
that's out there is not only raising valuations, but the speed at which people are putting it out
and the expectation that they're going to be able to raise a subsequent fund, the LP illiquidity,
something that we never asked in our second fund or our third fund, which we asked explicitly
in our fourth or fifth fund, was to LPs, how much money do you have targeted for the asset class
and how much do you actually have invested? And if somebody was like, we have a 4% target for venture
capital out of an 8% target of PE, and we're 12% allocated. We would say, thank you very much. It's
great to meet you. We would not take their money. Why? I don't want my name ending up on a secondary
list because they've got some denominator effect in two years, and we have to deal with their
liquidity. So we, in the early days, we'd be delighted to raise money from whoever we can.
Now we're really judicious, both about the mission that they're fulfilling, but also their own
liquidity. So venture way too much money. Price is way too high. I think the natural corrective to that
is eventually failure, but the problem with Ventures, you have 10-year asset class where people can
sort of fake it and keep these things going for a very long time. The other natural corrective is doing
new COs. I don't like golf, I like basketball growing up in Brooklyn, and the ability to have
ball control. And the way you have ball control is you start a company. You control the price. You control
who you're letting into the syndicate. And so we're going to be doing a lot of those over the next few
years. And then I think also something that we haven't been doing over the past few years, but we did
post-08 crisis were special situations. When the cost of capital is low,
or negative, as it is essentially globally, and now maybe starting to tick up, every company is special
because they've got tons of money. But once you hear that sucking sound, to me, that's a whistle.
Pay attention. And wherever capital is starting to get scarce, you know, you're going to have,
you don't want to catch falling knives. There's going to be a lot of companies that just end up going
out of business, but there are going to be some great teams with great balance sheets, but really impaired
cap tables. And if you can find those impaired cap tables where there's corporate VCs, record
levels of investment, always a contrarian indicator. They're always investing at the top of
cycles. People on the LP side, which is a little bit concerning, that historically we're doing
just LP allocations now have direct programs. Individuals are starting VC firms at record
rates. People are leaving the McKinsey's and the Goldman's and opening up shop and starting
venture. And some of them will get lucky and persist. And the vast majority won't. And that's the beauty
of markets, right? It's messy. It's not predictable. But I think it would be irresponsible to not
see it and just be really cautious. How does that opinion affect how you,
run Lux as a business? Some of it is the pace of investing. Some of it is making sure that we are good
stewards, not only of our capital, but good partners to other people. We have syndicates that,
you know, we've sort of come up in the business with who we like, we reciprocate. There's a lot of,
you know, chit trading, both reputationally and amongst deals, being good actors, because I think
the capital will come and go, but your reputation, and I've seen just people with horrible
reputations that made a ton of money and they're blown out of the industry. And so just being good
actors, being thoughtful, being methodical, being wary of risk and not caught up in, like,
you know, this hype because I think just so many sectors right now are just totally overdone.
And I think that there's a lot of lying.
I think there's fraudulent companies.
I mean, it's amazing you see these companies.
Everything's great.
Everything's great.
And it's like, you know, Turkey before Thanksgiving, then they're out.
They're dead.
And it's like, well, what happened?
That was a quick phase transition.
And it's because they couldn't go to the market and be like, we're having trouble.
And so you're seeing these, you know, some of these uniforms.
unicorns that are just going a zero. And there's no, you know, there's total discontinuity between
the last round and then just going bankrupt. Interesting side story that's happening is the cryptocurrency
crash right now where talk about abundance of capital, right? Like ridiculous amounts of money
being raised to effectively, on a white paper, oftentimes fraudulently curious your take on
crypto as an idea, maybe as an asset class, whether you consider it an asset class, just your
general thoughts. My view is you have to understand both sides of it, right? So I understand the view
that this is a tulip bubble. It is the measure as money itself is, you know, of people's belief
that, you know, you mentioned sapiens before. So if you think about, you know, you've got
objective, subjective, and intersubjective reality, money doesn't really exist. But for the fact that
I believe that you believe that infinite item, I can't give you a monopoly dollar and, you know,
get that cup of coffee from you. I can give you Bitcoin because you believe that somebody else
believes that, you know. And so as an intersubjective belief, it's real because people believe in it.
And everybody says, you know, well, blockchain is going to be super
interesting. And I think people are starting to say, well, wait a second, what are the actual
incarnations of this? And so my view is that this will probably be more akin to that
combinatorial fodder that comes from the detritus, mass failures, that somebody then picks up
the pieces in the same way that happened post-internet where, you know, what got laid and lit were
all these fiber optic cables that begot, you know, the internet 2.0 and the Facebooks and the
YouTube's and all the stuff that didn't exist in the first boom. Something will come from that.
So anyway, so that's the first view, which is approximating everything of a bubble. You know, you see
the curve now with the crash. The other view, and you know, you have interesting people like Murray Stahl
from Horizon Kinetics, you know, has a really interesting take on it. Bill Miller, obviously, you know,
he admits it was a speculative investment and they've sort of parsed that off. There's really
rational people that have said, I'm speculating basically on the belief of what might be. I do accept
that in extremist, if you, you know, what's the value of Bitcoin? And I used to ask people this,
and they never had a good answer. And I actually, you know, worked and did calculation with people.
And it's like, okay, if you took the sum total of all the currency in the world, and
divided by some money multiplier and you assume that you had, you know, forgetting about the unlimited
forking and unlimited production of other cryptos, but just Bitcoin, you know, that you would have a
value. And the reason that that would never be realized is because you have people, specifically
people who run countries. And those people want to be able to issue debt and inflate their currency
and control their people. And so as long as that exists. I mean, the great irony was the reason
that people were embracing this was that it was a rejoinder to sovereign control of.
currency. And so people in Argentina or Venezuela that were trying to get money out, you know,
that was one case of actual use. But then South Korea says, we're going to ban it. And then it
crashes 10 or 15 percent that day. And so I just think that this is going to be a messy thing.
Nobody actually knows what's going to happen. The high confidence thing I have is that something
great will come of it and I have no idea what, but it's not what everybody is talking about today.
Talk a bit about San Fe Institute. We haven't talked on the air yet about that. Your experience
with it. Maybe for those unfamiliar, just describe what it is. It is the birthplace of, you know,
complexity science. It is looking at an emergent phenomenon and it is looking them across disciplines.
So you will have people that study geology and earthquakes, people that study ant colonies,
people that study disease and epidemic progression inside of populations, people that study stock
markets, people that look at mating calls of birds and compare that to the frequency modulation
inside of, you know, spectrum auctions of countries. I got introduced to it through Michael
Mobison, who was a brilliant strategist and, you know, voracious reader and a dear friend,
and another friend Bill Miller. And Bill is one of these.
guys who, to me, as a philosopher, you know, like your background, really interested in non-obvious
ideas. And could you go into other people's domains, sort of like a Charlie Munger, and pull out
really big ideas and then apply them to an investing process? And so he did that very early on,
became chairman, recruited Michael, Michael became chairman, Michael recruited me. I've become chair of the
nominating committee. We've brought on some amazing people, most recently Bill Gurley and Jim
Pilate and some others to join. And it's this collection of scientific minds and curious people.
and there's no direction.
They get to choose what they want to focus on,
but they're inspired to really go after really big things.
And the guy that runs it is this guy, David Crackhauer,
who is the prodigal son who was sort of asked to leave maybe like years ago
because he was too disruptive, and he comes back to run it.
And he's like this Steve Jobsian figure.
He's got a cool British accent,
and he's this champion of science, but total champion of rebels.
He wants the scientists to go and think big, crazy, non-practical ideas,
and they come up with all kinds of crazy stuff,
and I get inspired by it,
because it's either an idea that I can pull that might affect one of our companies,
or it's a way that process-wise we can forge for new ideas or a way to organize and think about our time.
But it's just really this intellectual smorgas board, and I love it.
It's just an amazing place.
Makes me jealous, and I've never experienced it yet, maybe someday.
We got to get you there.
What is the most memorable conversation that you've ever had?
Oh, that's a great question.
I'll give you the pedestrian one.
The salience of memory is coupled to the emotional response you have.
So the most important conversation, the most memorable, was when we went to Bill Conway of Carlisle,
and I was talking about all these crazy areas of emerging tech, and I said, I want to put our money where our mouth is now, you know, in the space.
And actually, I want to put your money where our mouth is.
And whatever it was that day, I got lucky, right?
I mean, Mobison is a big student of skill versus luck.
But whatever the circumstances, he had a good day.
Maybe he made money for his LPs.
Maybe the firm was going good.
Maybe somebody just complimented.
And maybe his team just, I don't know what it was, but that day, he said, looked at me,
he said, I hope you make a billion.
And he backed us.
I mean, it was like the most fortunate day of my life.
And so I never forget that because I'm going to hopefully make that mark on somebody else.
But that to me was a hugely memorable.
And second one, by the way, I remember first board meeting for Kaimetta, we're in Bill Gates' office.
And, you know, you think billionaire, richest man in the world, you're going to have, you know,
chefs and people waiting on you and, you know, four-course meal and this kind of thing.
I remember at that meeting, sitting down for lunch, calling my wife after excitedly, because I have
a very pedestrian ballot.
I mean, Coney Island, hot dogs, Nathan's, you know, and I'm like, you're never going to guess
what we had for lunch.
She's like, what?
Filet mignon.
I'm like, California Pizza Kitchen.
And it was just amazing.
It's just like they're regular people.
And the circumstances and the fame and all this, but it's just, you know, regular people.
So, but the best advice I ever got was Jim Watson, who co-discovered DNA, and Jim is brilliant, and
as many brilliant people are a little bit crazy. And Jim has this admonishment, which is double
meaning, three words, avoid boring people. And I love it because what he's saying is stay away
from people who are not interesting, avoid boring people, and avoid boring people. Don't be boring
to people, be interesting. So I have information anxiety because I need to know and want to know
something about everything, whether that's poetry or literature or science or sports or whatever
it is. I need to know something so that I'm never in a conversation and be like,
like, oh, okay, yeah, you know, nodding my head.
Like, I want to be able to converse about everything.
So I've seen you talk about entropy before.
Obviously, you have informational phomo, and you're doing a lot.
What is your objective function?
Like, what are you optimizing for to even think about it like that?
In the long run, as Kane said, we're all dead.
Yes.
So, and you're an atheist, or not religious, I should say.
I am an atheist.
So how do you think about that?
This is a big philosophical question, but seems appropriate.
So entropy to me, I think, is one of the not widely understood and most important concepts,
because I think it is one of these universal Santa Fe-like phenomenon that pervades everything.
Your room is a mess unless you put energy into the system, right?
It trends towards disorder.
The universe itself, life is a fight against heat death and entropy.
So your metabolism and consuming food and structure and order and muscle building and all of that and sleep,
everything is to fight entropy.
businesses will trend towards disorder.
By the way, I would trend towards disorder if I didn't have the entropy of a partnership
and people that would keep me focused on certain things, be like, come out of that rabbit
hole, right?
Here's disconfirming evidence.
And so I think it's a really useful function because you can see it in cities, you can see
it in organisms, you can see it in businesses, you can see it in markets.
Anytime that there's massive disorder, there's an opportunity for energy to come in and organize.
And that includes ideas.
And so when you see something in our world that sucks and you say, well, that's chaotic.
I mean, we're sitting here in a conference room.
This sucks.
The conference equipment.
There is not a person listening right now that has not become accustomed to and accepted that
conference calls never start on time, that they don't work, that video conferencing sucks,
that you all have the same crappy polycom system, you know, et cetera.
That's an opportunity for somebody to organize all the disorder in a market.
Anyway, so objective function, number one, is don't die, right?
Survive.
Make good decisions.
avoid making bad decisions.
I do, and sort of inspired by Charlie Munger, keep records of people that have made really bad
decisions.
Because through them, people can always celebrate.
And I've debated this with Peter Thiel where he's like, you know, you only want to focus
on people that have been really successful.
And I totally disagree because a lot of that has been luck.
But I think if you focus on people that have really screwed up because they've made bad choices,
you know, that's something to avoid.
So survive is number one, having children.
And you've got two?
I've got three.
To me, it is the most important thing in life.
And some people don't want to have kids.
and something, but I just, to me, it's everything.
Aside from the biological function, the role model that I can be for them, the
optionality that I can create for them, and by the way, making sure that I don't screw things
up by giving them too good of a life, that they lack the very thing that I had, which was
this adversity and not having money and all that.
So I haven't figured it out, but that to me is the objective function is, and by the way,
happiness is not that, right?
I don't believe that you can achieve the state of permanent happiness.
I don't believe it's in the human condition.
And I think you can have punctuated periods, you know, sort of cultivated happiness.
You can have perspective that gives it to you.
But I think we need dissatisfaction for continued progress.
And I have to be dissatisfied that my kids have not achieved enough or I've not achieved enough or we don't have enough or we're not giving back enough or whatever it is that just keeps you going.
We've talked a lot about being a contrarian or thinking in contrarian terms.
Is there a person or people that you disagree with but deeply respect?
I mean, the number one would probably be Bill Conway in that I respect him and enormously credit my entire business success, you know, to this man believing. And he is a deeply religious guy. And I respect him and I respect that. I think his morals and ethics come from it. I think, you know, he never, it didn't matter what the deal documents said or the legal document said. He would do the right thing. And I think that comes from a profound religious belief and I respect that. But I totally, you know, disagree with it. I mean, I have a very scientific worldview and the absence of evidence.
you know, there is a high bar for me to believe something.
I'm an empiricist.
But that would be probably the great example of somebody who I ad hominem have huge respect for,
but fundamentally disagree with what they believe.
So my closing question for everybody is for the kindest thing that anyone's ever done for you.
Again, I mean, it may be recency bias here, but Bill putting us in business.
What's number two?
My wife saying yes.
I don't know.
I mean, I think there are amazing acts of kindness.
This one's going to sound a little bit negative.
but one of the happiest moments of my life.
You know, if you remember, I like people
that sort of come from broken backgrounds
and have something,
but my father was not a significant part of my life,
and there was a lot of animosity between him and my mother
and divorce and custody battles
and all kinds of crazy stuff.
And there was a moment a few years into Lux
when I was speaking to my father,
and he told me a story that somebody heard his name
and said, wait a second, you're Josh Wolf's father?
And that was like a really proud moment.
moment for me. I don't know. That always has and will stick with me. Well, we'll stick with me from
this conversation is to be absolutely relentless and insatiably curious. I've learned a tremendous
amount today. So thank you for your time. I love listening to you. So I'm really honored to be here.
Hey, everyone. Patrick here again. To find more episodes of Investor like the best, go to investorfield
guide.com forward slash podcast. If you're a book lover, you can also sign up for my book club
at Investorfieldguide.com forward slash book club.
After you sign up, you'll receive a full investor curriculum right away,
and then three to four suggestions of new books every month.
You can also follow me on Twitter at Patrick underscore Oshag,
OSHAG.
If you enjoy the show, please leave a quick review for us on iTunes,
which will help more people discover Invest Like the Best.
Thanks so much for listening.
